ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,466,732 | +53.0% | 128,074 | +69.5% | 0.01% | +40.0% |
| Q1 2024 | $11,419,382 | +5098.7% | 75,540 | +4231.4% | 0.01% | – |
| Q4 2023 | $219,657 | +214.9% | 1,744 | +134.1% | 0.00% | – |
| Q3 2023 | $69,762 | -17.5% | 745 | -21.4% | 0.00% | – |
| Q2 2023 | $84,609 | -18.2% | 948 | -1.8% | 0.00% | – |
| Q1 2023 | $103,467 | +134.0% | 965 | +166.6% | 0.00% | – |
| Q4 2022 | $44,211 | -99.9% | 362 | -54.8% | 0.00% | – |
| Q3 2022 | $82,608,000 | +22.6% | 800 | +10.3% | 0.00% | – |
| Q2 2022 | $67,396,000 | -95.5% | 725 | -93.5% | 0.00% | -100.0% |
| Q4 2021 | $1,505,525,000 | +10.5% | 11,191 | -7.5% | 0.00% | -33.3% |
| Q1 2020 | $1,362,581,000 | – | 12,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |